The role of chemoradiotherapy in curative treatment of head and neck cancer
Thieme. All rights reserved..
Radiotherapy and chemotherapy are integral parts of definitive and adjuvant therapy in the treatment of head and neck squamous cell carcinoma (HNSCC). The outcome of therapy is essentially dependent on selection and dosage of chemotherapeutical substances and on the other hand on the radiotherapeutical setting concerning fractionation, time of therapy and technical aspects. Immunotherapeutical substances have an increasing role in the therapy of HNSCC as well as particle therapy is investigated as part of radiotherapy in actual studies. Further challenges relate to treatment of HPV-induced tumors with regard to their differences in tumor biology and consecutively better prognosis.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:101 |
|---|---|
| Enthalten in: |
Laryngo- rhino- otologie - 101(2022), 1 vom: 28. Jan., Seite 22-34 |
| Sprache: |
Deutsch |
|---|
| Weiterer Titel: |
Kurative Radiochemotherapie von Kopf-Hals-Tumoren |
|---|
| Beteiligte Personen: |
Langer, Christine [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 05.01.2022 Date Revised 05.01.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/a-1351-0417 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320681696 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320681696 | ||
| 003 | DE-627 | ||
| 005 | 20231225174110.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2022 xx |||||o 00| ||ger c | ||
| 024 | 7 | |a 10.1055/a-1351-0417 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1068.xml |
| 035 | |a (DE-627)NLM320681696 | ||
| 035 | |a (NLM)33506441 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ger | ||
| 100 | 1 | |a Langer, Christine |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The role of chemoradiotherapy in curative treatment of head and neck cancer |
| 246 | 3 | 3 | |a Kurative Radiochemotherapie von Kopf-Hals-Tumoren |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2022 | ||
| 500 | |a Date Revised 05.01.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Thieme. All rights reserved. | ||
| 520 | |a Radiotherapy and chemotherapy are integral parts of definitive and adjuvant therapy in the treatment of head and neck squamous cell carcinoma (HNSCC). The outcome of therapy is essentially dependent on selection and dosage of chemotherapeutical substances and on the other hand on the radiotherapeutical setting concerning fractionation, time of therapy and technical aspects. Immunotherapeutical substances have an increasing role in the therapy of HNSCC as well as particle therapy is investigated as part of radiotherapy in actual studies. Further challenges relate to treatment of HPV-induced tumors with regard to their differences in tumor biology and consecutively better prognosis | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Wittekindt, Claus |e verfasserin |4 aut | |
| 700 | 1 | |a Jensen, Alexandra Désirée |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Laryngo- rhino- otologie |d 1995 |g 101(2022), 1 vom: 28. Jan., Seite 22-34 |w (DE-627)NLM012616737 |x 1438-8685 |7 nnns |
| 773 | 1 | 8 | |g volume:101 |g year:2022 |g number:1 |g day:28 |g month:01 |g pages:22-34 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-1351-0417 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 101 |j 2022 |e 1 |b 28 |c 01 |h 22-34 | ||